zidovudine has been researched along with trovirdine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Bell, FW; Cantrell, AS; Högberg, M; Jaskunas, SR; Johansson, NG; Jordan, CL; Kinnick, MD; Lind, P; Morin, JM; Noréen, R | 1 |
Mao, C; Sudbeck, EA; Uckun, FM; Venkatachalam, TK; Vig, R | 1 |
Mao, C; Sudbeck, EA; Uckun, FM; Venkatachalam, TK | 1 |
Maher, D; Mao, C; Pendergrass, S; Tuel-Ahlgren, L; Uckun, FM; Venkatachalam, TK; Zhu, D | 2 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Böttiger, D; Fleckenstein, B; Haseltine, WA; Hunsmann, G; Kaup, FJ; Li, J; Mätz-Rensing, K; Oberg, B; Stahl-Hennig, C; Uberla, K | 1 |
Aubertin, AM; Ciurea, A; Delbederi, Z; Fossey, C; Gavriliu, D; Ladurée, D; Laumond, G; Schmidt, S; Sugeac, E | 1 |
8 other study(ies) available for zidovudine and trovirdine
Article | Year |
---|---|
Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.
Topics: Animals; Antiviral Agents; Cell Line; HIV-1; Humans; Isothiocyanates; Rats; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Thiourea | 1995 |
Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Topics: Antiviral Agents; Binding Sites; Computer Simulation; Drug Design; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocytes, Mononuclear; Models, Molecular; Piperazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiourea; Virus Replication | 1998 |
Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus.
Topics: Anti-HIV Agents; Delavirdine; Drug Design; Humans; Inhibitory Concentration 50; Kinetics; Models, Molecular; Nevirapine; Pyridines; Thiourea | 1999 |
N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1.
Topics: Aminopyridines; Anti-HIV Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Reverse Transcriptase Inhibitors; Thiourea | 1999 |
N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1.
Topics: Anti-HIV Agents; Cells, Cultured; HIV-1; Humans; Microbial Sensitivity Tests; Models, Molecular; Pyridines; Reverse Transcriptase Inhibitors; Thiourea; Virus Replication | 1999 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.
Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Animals; Antiviral Agents; Base Sequence; Cell Line; Disease Models, Animal; DNA Primers; HIV Reverse Transcriptase; HIV-1; Macaca fascicularis; Macaca mulatta; Molecular Sequence Data; Pyridines; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Zidovudine | 1995 |
Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase.
Topics: Anti-HIV Agents; Dideoxynucleosides; Dimerization; Drug Evaluation, Preclinical; HIV Reverse Transcriptase; HIV-1; Humans; Lymphocytes; Pyridines; Reverse Transcriptase Inhibitors; Stavudine; Tumor Cells, Cultured; Zidovudine | 2002 |